BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32292503)

  • 1. circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma.
    Li W; Yang FQ; Sun CM; Huang JH; Zhang HM; Li X; Wang GC; Zhang N; Che JP; Zhang WT; Yan Y; Yao XD; Peng B; Zheng JH; Liu M
    Theranostics; 2020; 10(10):4395-4409. PubMed ID: 32292503
    [No Abstract]   [Full Text] [Related]  

  • 2. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.
    Li J; Huang C; Zou Y; Ye J; Yu J; Gui Y
    Mol Cancer; 2020 Jun; 19(1):103. PubMed ID: 32503552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
    Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W
    Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380
    [No Abstract]   [Full Text] [Related]  

  • 4. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
    Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
    Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA MYLK promotes tumour growth and metastasis via modulating miR-513a-5p/VEGFC signalling in renal cell carcinoma.
    Li J; Huang C; Zou Y; Yu J; Gui Y
    J Cell Mol Med; 2020 Jun; 24(12):6609-6621. PubMed ID: 32342645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR-92a-2-5p/KLLN Pathway.
    Gao L; Shao X; Yue Q; Wu W; Yang X; He X; Li L; Hou F; Zhang R
    Oxid Med Cell Longev; 2021; 2021():9970272. PubMed ID: 34646428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway.
    Li R; Luo S; Zhang D
    Gene; 2020 Sep; 754():144811. PubMed ID: 32464246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
    Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L
    Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of circATG9A as a novel biomarker for renal cell carcinoma.
    Shen Y; Wu R; Zhuo Z; Deng X; Li W; Liu C
    Cancer Gene Ther; 2024 Jan; 31(1):82-93. PubMed ID: 37945969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition.
    Xiong J; Liu Y; Luo S; Jiang L; Zeng Y; Chen Z; Shi X; Lv B; Tang W
    Oncotarget; 2017 Jan; 8(4):6555-6563. PubMed ID: 28030807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
    Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
    J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.
    Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J
    Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928
    [No Abstract]   [Full Text] [Related]  

  • 15. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p.
    Wei S; Zheng Y; Jiang Y; Li X; Geng J; Shen Y; Li Q; Wang X; Zhao C; Chen Y; Qian Z; Zhou J; Li W
    EBioMedicine; 2019 Jun; 44():182-193. PubMed ID: 31160270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition.
    Chen X; Chen RX; Wei WS; Li YH; Feng ZH; Tan L; Chen JW; Yuan GJ; Chen SL; Guo SJ; Xiao KH; Liu ZW; Luo JH; Zhou FJ; Xie D
    Clin Cancer Res; 2018 Dec; 24(24):6319-6330. PubMed ID: 30305293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
    Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
    DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2.
    Zhou B; Zheng P; Li Z; Li H; Wang X; Shi Z; Han Q
    Cell Cycle; 2018; 17(23):2644-2654. PubMed ID: 30488762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.
    Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
    Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma.
    Sekino Y; Sakamoto N; Goto K; Honma R; Shigematsu Y; Quoc TP; Sentani K; Oue N; Teishima J; Kawakami F; Karam JA; Sircar K; Matsubara A; Yasui W
    BMC Cancer; 2018 Oct; 18(1):952. PubMed ID: 30286729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.